Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-14

Clinical Trial Update: Efficacy of 1% Metformin Gel Mixed With PRF in Augmenting Narrow Ridge [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of 1% metformin gel mixed with PRF to augment narrow ridge; condition listed as Horizontal Ridge Deficiency. Status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin Gel (1%) (metformin)
  • PRF (Platelet-rich fibrin)

Snippet

Sponsor: Al-Azhar University | Conditions: Horizontal Ridge Deficiency | Phase 3 | Status: UNKNOWN